Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic history of Cambridgeshire before and after the Black Death. | Sci Adv | 2024 | 38232165 | PubTator, text mining | PubMed |
| Simultaneous substrate and ubiquitin modification recognition by bispecific antibodies enables detection of ubiquitinated RIP1 and RIP2. | Sci Signal | 2024 | 38227684 | PubTator, text mining | PubMed |
| Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). | Respir Res | 2024 | 38218783 | PubTator, text mining | PubMed |
| Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity. | J Med Chem | 2024 | 38197367 | PubTator, text mining | PubMed |
| Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease. | Sci Rep | 2024 | 38191507 | PubTator, text mining | PubMed |
| Identification of novel biomarkers based on lipid metabolism-related molecular subtypes for moderately severe and severe acute pancreatitis. | Lipids Health Dis | 2024 | 38169383 | PubTator, text mining | PubMed |
| Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. | J Exp Clin Cancer Res | 2024 | 38167055 | PubTator, text mining | PubMed |
| Receptor-interacting protein kinase 2 is associated with tumor immune infiltration, immunotherapy-related biomarkers, and affects gastric cancer cells growth in vivo. | J Cancer | 2024 | 38164277 | PubTator, text mining | PubMed |
| Deep Learning Prediction Boosts Phosphoproteomics-Based Discoveries Through Improved Phosphopeptide Identification. | Mol Cell Proteomics | 2024 | 38154692 | PubTator, text mining | PubMed |
| LACC1 Promoted Nerve Injury in an Anesthesia-Induced Cognitive Disorder Model via RIP2 Expression through ROS-NOD2 Induction. | Altern Ther Health Med | 2024 | 38064597 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of novel thieno[2,3d]pyrimidine derivatives as potent and specific RIPK2 inhibitors. | Bioorg Med Chem Lett | 2024 | 38008339 | PubTator, text mining | PubMed |
| LUBAC is required for RIG-I sensing of RNA viruses. | Cell Death Differ | 2024 | 38001254 | PubTator, text mining | PubMed |
| Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer. | Cancer Discov | 2024 | 37824278 | PubTator, text mining | PubMed |
| A green one-pot synthetic protocol of hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one derivatives: molecular docking, ADMET, anticancer and antimicrobial studies. | Mol Divers | 2024 | 37566199 | PubTator, text mining | PubMed |
| Lactobacilli Probiotics Modulate Antibacterial Response Gene Transcription of Dendritic Cells Challenged with LPS. | Probiotics Antimicrob Proteins | 2024 | 36696085 | PubTator, text mining | PubMed |
| Identification of a chemical probe for lipid kinase phosphatidylinositol-5-phosphate 4-kinase gamma (PI5P4Kγ). | Curr Res Chem Biol | 2023 | 41937984 | PubTator, text mining | PubMed |
| Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease. | Front Immunol | 2023 | 38259437 | PubTator, text mining | PubMed |
| Dendritic cells: the yin and yang in disease progression. | Front Immunol | 2023 | 38239364 | PubTator, text mining | PubMed |
| Postbiotics: Functional Food Materials and Therapeutic Agents for Cancer, Diabetes, and Inflammatory Diseases. | Foods | 2023 | 38201117 | PubTator, text mining | PubMed |
| The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis-A Literature Review. | Biomedicines | 2023 | 38137365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=8